The PIONEER 4 study found that 14mg oral semaglutide lowered HbA1c by 1.2% over 26 weeks when added to metformin
Key Benefits: Lightens skin by inhibiting melanin production
Available long-term data shows no major concerns, though data beyond 12 weeks of continuous use is limited
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide acts on GLP-1 receptors alone and tirzepatide targets both GIP and GLP-1 receptors
Often called the master antioxidant, it exists naturally in your body in two formsreduced glutathione (GSH) and oxidized glutathione (GSSG)
For this population, recommendations should emphasize shifting dietary fat intake and adjusting macronutrient distribution, specifically, reallocating calories to fiber-rich carbohydrates and protein